Cerno Bioscience

Cerno Bioscience, founded in 2005 and headquartered in Salt Lake City, Utah, is a specialized software provider in the analytical instrumentation sector. The company has developed a patented, vendor-neutral software platform that significantly improves the performance and data interpretation capabilities of mass spectrometers without requiring changes to existing hardware or wet-lab workflows. With over 2,000 licenses sold globally, Cerno serves a diverse customer base in drug development, applied markets, and research, positioning itself as a key enabler for laboratories seeking to extract deeper insights from their capital equipment investments. Its business model is based on licensing its software solutions, generating revenue through direct sales and evaluations.

Vendor-neutral software platform using proprietary algorithms and spectral calibration to dramatically improve the mass accuracy and spectral interpretation capabilities of existing mass spectrometers (MS). The platform enables high-confidence compound identification and structural elucidation for both small and large molecules across LC-MS and GC-MS systems.

Cerno competes in the mass spectrometry software market against the dominant instrument OEMs (Agilent, Thermo Fisher, Waters, Sciex) who provide native software, as well as other third-party software vendors like HighChem (MassFrontier), Sierra Analytics, and MS-DIAL. Its key differentiator is its vendor-agnostic, performance-enhancing approach that works across any installed instrument, a niche less served by OEMs focused on their own ecosystems.